Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Conference News STS 2025

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Yael L. Maxwell

February 05, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

Yael L. Maxwell

May 01, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

News Daily News

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Caitlin E. Cox

January 25, 2022

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

Advertisement

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

TCTMD’s Top 10 Most Popular Stories for October 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’

Top Structural Heart News of 2024

STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content